Exploring Cassiopeia Part 2: Daratumumab's Role in Myeloma Treatment

This chapter explores the findings of the Cassiopeia Part 2 clinical trial, which tests the effectiveness of daratumumab in myeloma patients post-auto stem cell transplant. It also addresses critiques of the trial's design and the ethical implications of using observation as a control group.